Elizabeth Sakach, MD

Background

A medical oncologist, Dr. Sakach is passionate about treating patients with breast cancer. Her goal is to meet her patients with empathy and understanding, offering state-of-the-art care through a shared decision making approach. She joined the Glenn Family Breast Center at Winship Cancer Institute in 2023.

Dr. Sakach earned her medical degree from Texas A&M College of Medicine in College Station, Texas. She completed her residency in internal medicine and fellowship in hematology and medical oncology at Emory University School of Medicine in Atlanta, Georgia, where she served as chief fellow in her final year. She completed a fellowship in cancer drug development with the FDA-AACR through the Oncology Educational Fellowship program.

Dr. Sakach's research is focused on the investigation of mechanisms of resistance and novel therapeutics for patients with advanced breast cancer. She serves as principal investigator for several therapeutic trials for patients with breast malignancies at Winship Cancer Institute.

Dr. Sakach has presented her research on breast cancer at national meetings and has published her work in peer-reviewed journals including Journal of Clinical Oncology and Clinical Breast Cancer.

Titles & Roles

• Assistant Professor, Department of Hematology and Medical Oncology

  Emory University School of Medicine

Education & Training

Education

• Fellowship, Hematology/Oncology, 2023

  Emory University School of Medicine
• Residency, Internal Medicine, 2020

  Emory University School of Medicine
• Medical Education, , 2017

  Texas A&M Health Science Center

Board Certifications

• Internal Medicine

  American Board of Internal Medicine, 2020

Professional Memberships

American Society of Clinical Oncology

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.